Evaluation of circulating cell-free DNA as a molecular monitoring tool in patients with metastatic cancer

The clinical decisions made when treating patients with metastatic cancer require knowledge of the current tumor extent and response to therapy. For the majority of solid tumors, a response assessment, which is based on imaging, is used to guide these decisions. However, measuring serum protein biom...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Oncol Lett
Prif Awduron: Hufnagl, Clemens, Leisch, Michael, Weiss, Lukas, Melchardt, Thomas, Moik, Martin, Asslaber, Daniela, Roland, Geisberger, Steininger, Philipp, Meissnitzer, Thomas, Neureiter, Daniel, Greil, Richard, Egle, Alexander
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: D.A. Spandidos 2020
Pynciau:
Articles
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC6956108/
https://ncbi.nlm.nih.gov/pubmed/31966080
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2019.11192
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg